InflaRx (IFRX) Return on Equity [ROE] (2017 - 2026)
InflaRx (IFRX) recorded Return on Equity [ROE] of -49852548.49% in Q2 2026, down 49852548.49 percentage points from 0.00% a year earlier but up 66176269.69 percentage points from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2025, InflaRx reported Return on Equity [ROE] of -91592570.18%, down 35656184.29 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three straight years, with a five-year change of -53517323.41 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -55936385.89% in FY2024 (-10145469.33 pp), -45790916.55% in FY2023 (-17220235.27 pp), -28570681.28% in FY2022 (+20379764.65 pp) and -48950445.93% in FY2021 (-10875199.17 pp).
- Quarterly Return on Equity [ROE] has ranged from -116028818.18% in Q1 2026 to 0.00% in Q3 2025 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has declined for three consecutive quarters, with an average year-over-year change of -33830394.24 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 41008905.11 percentage points in Q4 2021, against a drop of 116028686.45 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -116028818.18% (Q1 2026), -104762046.45% (Q4 2025) and 0.00% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | InflaRx | 104.63 Mn | -228.98 Mn | 2.74 Mn | -43.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.63% |
| Mar 31, 2026 | -108.87% |
| Dec 31, 2025 | -101.50% |
| Sep 30, 2025 | -74.76% |
| Jun 30, 2025 | -69.47% |
| Mar 31, 2025 | -68.94% |
| Dec 31, 2024 | -73.18% |
| Sep 30, 2024 | -76.70% |
| Jun 30, 2024 | -53.24% |
| Mar 31, 2024 | -41.40% |
| Dec 31, 2023 | -38.70% |
| Sep 30, 2023 | -28.55% |
| Jun 30, 2023 | -33.46% |
| Mar 31, 2023 | -30.66% |
| Dec 31, 2022 | -32.71% |
| Sep 30, 2022 | -36.88% |
| Jun 30, 2022 | -41.27% |
| Mar 31, 2022 | -55.21% |
| Dec 31, 2021 | -42.62% |
| Sep 30, 2021 | -35.59% |
API Access
InflaRx Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();